Abstract

Metabolic syndrome and its associated conditions, such as obesity and type 2 diabetes mellitus (T2DM), are a major public health issue in modern societies. Dietary interventions, including microbiota-directed foods which effectively modulate the gut microbiome, may influence the regulation of obesity and associated comorbidities. Although research on probiotics and prebiotics has been conducted extensively in recent years, diets with the use of synbiotics remain relatively unexplored. Here, we investigated the effects of a novel synbiotic intervention, consisting of an adlay seed extrusion cooked (ASEC)-based prebiotic and probiotic (Lactobacillus paracasei and Bacillus coagulans) on metabolic disorders and microbial dysbiosis in high-fat diet (HFD)-induced obese mice. The ASEC-based synbiotic intervention helped improve HFD-induced body weight gain, hyperlipidemia, impaired glucose tolerance, insulin resistance, and inflammation of the adipose and liver tissues. In addition, data from fecal metagenomics indicated that the ASEC-based synbiotic intervention fostered reconstitution of gut bacterial diversity and composition in HFD-induced obese mice. In particular, the ASEC-based synbiotic intervention increased the relative abundance of families Ruminococcaceae and Muribaculaceae and order Bacteroidales and reduced that of families Lactobacillaceae, Erysipelotrichaceae, and Streptococcaceae in HFD-induced obese mice. Collectively, our results suggest that delayed dietary intervention with the novel ASEC-based synbiotic ameliorates HFD-induced obesity, metabolic disorders, and dysbiosis.

Highlights

  • IntroductionMetabolic syndrome, characterized by abdominal obesity, insulin resistance, hypertension, and hyperlipidemia, increases the onset of cardiovascular diseases (CVD) and type 2 diabetes mellitus (T2DM) and has a prevalence of 20–25% in a meta-analysis of the adult population [1]

  • We aimed to determine whether intervention with adlay seed extrusion cooked (ASEC)-based prebiotic, probiotics (Lactobacillus paracasei and Bacillus coagulans; the PRO group), and the synbiotic ameliorates diet-induced obesity and metabolic disorders and modulates the abundance and diversity of the gut microbiota

  • 0.7% (g/g), we investigated whether incorporating adlay in the synbiotic formulation containing Lactobacillus paracasei and Bacillus coagulans improves metabolic disorders in

Read more

Summary

Introduction

Metabolic syndrome, characterized by abdominal obesity, insulin resistance, hypertension, and hyperlipidemia, increases the onset of cardiovascular diseases (CVD) and type 2 diabetes mellitus (T2DM) and has a prevalence of 20–25% in a meta-analysis of the adult population [1]. The microbiome of the human gastrointestinal (GI) tract houses trillions of microbial cells, among which about 1000 species of anaerobic bacteria are commonly found in each individual [4]. The gut microbiome participates in many human physiological processes, such as nutrient absorption, metabolism, and immune regulation [6]. Disruption of the gut microbiome has been found to influence the occurrence and development of many diseases, including intestinal inflammation, diabetes, obesity, food allergies, and malignancies [6]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call